# Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males

> **NCT01133548** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 62 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testosterone Gel 1.62%
- **DRUG:** Testosterone Gel 1.62%

## Key facts

- **NCT ID:** NCT01133548
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01133548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01133548, "Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01133548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*